These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12650949)

  • 1. Milnacipran in the treatment of bulimia nervosa: a report of 16 cases.
    El-Giamal N; de Zwaan M; Bailer U; Strnad A; Schüssler P; Kasper S
    Eur Neuropsychopharmacol; 2003 Mar; 13(2):73-9. PubMed ID: 12650949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reboxetine in the treatment of bulimia nervosa: a report of seven cases.
    El-Giamal N; de Zwaan M; Bailer U; Lennkh C; Schüssler P; Strnad A; Kasper S
    Int Clin Psychopharmacol; 2000 Nov; 15(6):351-6. PubMed ID: 11110011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
    Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
    Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Are psychotropic drugs necessary for the treatment of anorexia and bulimia nervosa?].
    Thiel A
    Psychother Psychosom Med Psychol; 1997; 47(9-10):332-45. PubMed ID: 9411463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of milnacipran on binge eating - a pilot study.
    Noma S; Uwatoko T; Yamamoto H; Hayashi T
    Neuropsychiatr Dis Treat; 2008 Feb; 4(1):295-300. PubMed ID: 18728825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment.
    Romano SJ; Halmi KA; Sarkar NP; Koke SC; Lee JS
    Am J Psychiatry; 2002 Jan; 159(1):96-102. PubMed ID: 11772696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine.
    Clerc G;
    Int Clin Psychopharmacol; 2001 May; 16(3):145-51. PubMed ID: 11354236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressants versus placebo for people with bulimia nervosa.
    Bacaltchuk J; Hay P
    Cochrane Database Syst Rev; 2003; (4):CD003391. PubMed ID: 14583971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial.
    Faris PL; Kim SW; Meller WH; Goodale RL; Oakman SA; Hofbauer RD; Marshall AM; Daughters RS; Banerjee-Stevens D; Eckert ED; Hartman BK
    Lancet; 2000 Mar; 355(9206):792-7. PubMed ID: 10711927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reboxetine in the treatment of bulimia nervosa].
    Castilho SM; Costa LH
    Braz J Psychiatry; 2003 Jun; 25(2):100-2. PubMed ID: 12975707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled comparison of milnacipran and fluoxetine in major depression.
    Ansseau M; Papart P; Troisfontaines B; Bartholomé F; Bataille M; Charles G; Schittecatte M; Darimont P; Devoitille JM; De Wilde J
    Psychopharmacology (Berl); 1994 Feb; 114(1):131-7. PubMed ID: 7846195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression.
    Goldstein DJ; Wilson MG; Ascroft RC; al-Banna M
    Int J Eat Disord; 1999 Jan; 25(1):19-27. PubMed ID: 9924649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group.
    Goldstein DJ; Wilson MG; Thompson VL; Potvin JH; Rampey AH
    Br J Psychiatry; 1995 May; 166(5):660-6. PubMed ID: 7620754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronopharmacological Analysis of Antidepressant Activity of a Dual-Action Serotonin Noradrenaline Reuptake Inhibitor (SNRI), Milnacipran, in Rats.
    Kawai H; Machida M; Ishibashi T; Kudo N; Kawashima Y; Mitsumoto A
    Biol Pharm Bull; 2018; 41(2):213-219. PubMed ID: 29386481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.
    Hoopes SP; Reimherr FW; Hedges DW; Rosenthal NR; Kamin M; Karim R; Capece JA; Karvois D
    J Clin Psychiatry; 2003 Nov; 64(11):1335-41. PubMed ID: 14658948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of severe antidepressant-induced nausea with a combination of milnacipran and olanzapine.
    Yoshida K; Higuchi H; Ozaki N
    Pharmacopsychiatry; 2007 Mar; 40(2):84-5. PubMed ID: 17447181
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.
    Hedges DW; Reimherr FW; Hoopes SP; Rosenthal NR; Kamin M; Karim R; Capece JA
    J Clin Psychiatry; 2003 Dec; 64(12):1449-54. PubMed ID: 14728106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LEVOMILNACIPRAN--A SUCCESSOR OF MILNACIPRAN WITH A HIGHER NORADRENERGIC SELECTIVITY.
    Zadka Ł; Dziwota E; Olajossy M
    Acta Pol Pharm; 2016; 73(2):285-9. PubMed ID: 27180420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT; Isaac MB; Gallo F; Tournoux A
    Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimensions of response to antidepressant agents in bulimia nervosa: a review.
    Wolfe BE
    Arch Psychiatr Nurs; 1995 Jun; 9(3):111-21. PubMed ID: 7625867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.